Mirae Asset Global ETFs Holdings’s Maravai LifeSciences MRVI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$346K	Buy	122,160 +4,932	+4%	+$16.7K	﹤0.01%	2075
2025 Q4	$381K	Sell	117,228 -10,949	-9%	-$36.9K	﹤0.01%	2028
2025 Q3	$368K	Sell	128,177 -18,379	-13%	-$46.9K	﹤0.01%	2018
2025 Q2	$353K	Sell	146,556 -94,480	-39%	-$199K	﹤0.01%	1991
2025 Q1	$533K	Sell	241,036 -7,730	-3%	-$30.5K	﹤0.01%	1836
2024 Q4	$1.36M	Buy	248,766 +188,163	+310%	+$1.21M	﹤0.01%	1377
2024 Q3	$504K	Buy	+60,603	New	+$524K	﹤0.01%	1907

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MRVI Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Maravai LifeSciences (MRVI) stake by 4.2% in Q1 2026, buying an estimated $16.7K and bringing the position to 122,160 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Mirae Asset Global ETFs Holdings first reported a position in MRVI in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.36M in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Mirae Asset Global ETFs Holdings held 122,160 shares of Maravai LifeSciences worth $346K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 4,932 Maravai LifeSciences shares in Q1 2026, an estimated $16.7K.
Maravai LifeSciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2075 holding.
Mirae Asset Global ETFs Holdings first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 7 quarters since.
Mirae Asset Global ETFs Holdings's Maravai LifeSciences position peaked at $1.36M in Q4 2024.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.